0.4914
전일 마감가:
$0.4497
열려 있는:
$0.4593
하루 거래량:
5.32M
Relative Volume:
0.20
시가총액:
$48.78M
수익:
-
순이익/손실:
$-12.89M
주가수익비율:
-0.1942
EPS:
-2.53
순현금흐름:
$-11.95M
1주 성능:
+7.76%
1개월 성능:
-25.32%
6개월 성능:
+40.40%
1년 성능:
-64.26%
Plus Therapeutics Inc Stock (PSTV) Company Profile
명칭
Plus Therapeutics Inc
전화
737.255.7194
주소
4200 MARATHON BLVD., AUSTIN, TX
PSTV을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PSTV
Plus Therapeutics Inc
|
0.4914 | 44.64M | 0 | -12.89M | -11.95M | -2.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-09-03 | 업그레이드 | D. Boral Capital | Hold → Buy |
2025-03-17 | 개시 | D. Boral Capital | Buy |
2021-01-25 | 개시 | Ladenburg Thalmann | Buy |
2020-10-16 | 개시 | Maxim Group | Buy |
Plus Therapeutics Inc 주식(PSTV)의 최신 뉴스
Can machine learning forecast Plus Therapeutics Inc. recovery2025 Price Action Summary & High Return Trade Guides - Newser
Tick level data insight on Plus Therapeutics Inc. volatilityM&A Rumor & AI Driven Price Forecasts - Newser
Can Plus Therapeutics Inc. hit a new high this monthWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Can Plus Therapeutics Inc. sustain its profitabilityEarnings Trend Report & Long-Term Safe Return Strategies - خودرو بانک
What is Plus Therapeutics Inc. s P E ratio telling usMarket Sentiment Report & Fast Gaining Stock Reports - خودرو بانک
Will Plus Therapeutics Inc. stock hit new highs in YEAR2025 Growth vs Value & Real-Time Market Sentiment Alerts - خودرو بانک
Can Plus Therapeutics Inc. benefit from deglobalizationJuly 2025 Institutional & Reliable Price Action Trade Plans - خودرو بانک
Growth Value: What is Plus Therapeutics Inc.’s valuation compared to sectorQuarterly Portfolio Review & Accurate Entry/Exit Alerts - خودرو بانک
What is Plus Therapeutics Inc.’s valuation compared to sectorTake Profit & Breakout Confirmation Trade Signals - خودرو بانک
Live market analysis of Plus Therapeutics Inc.Quarterly Growth Report & Capital Efficient Trading Techniques - Newser
What’s the recovery path for long term holders of Plus Therapeutics Inc. - Newser
Navigating Biotech Innovation Amid Sector Volatility: High-Conviction Opportunities in 2025 - AInvest
Is a relief rally coming for Plus Therapeutics Inc. holdersJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser
Plus Therapeutics Inc. recovery potential after sell offTake Profit & Precise Swing Trade Entry Alerts - Newser
Plus Therapeutics Inc. stock trendline breakdownWeekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Plus Therapeutics, Inc. shares rise 2.22% premarket after HUTCHMED highlights clinical data at conference. - AInvest
Backtesting results for Plus Therapeutics Inc. trading strategiesGold Moves & Safe Capital Investment Plans - Newser
Should you wait for a breakout in Plus Therapeutics Inc.2025 Big Picture & Daily Stock Trend Watchlist - Newser
How to read the order book for Plus Therapeutics Inc.Quarterly Market Summary & Verified Chart Pattern Signals - Newser
Visualizing Plus Therapeutics Inc. stock with heatmapsJuly 2025 Reactions & Verified Swing Trading Watchlist - Newser
Is Plus Therapeutics Inc. building a consolidation baseJuly 2025 Sentiment & Weekly Market Pulse Alerts - Newser
Multi asset correlation models including Plus Therapeutics Inc.Profit Target & AI Enhanced Trading Alerts - Newser
Forecasting Plus Therapeutics Inc. price range with options dataWeekly Risk Summary & Precise Trade Entry Recommendations - Newser
How to integrate Plus Therapeutics Inc. into portfolio analysis toolsOil Prices & AI Driven Price Forecasts - Newser
Screener Results Flag Plus Therapeutics Inc. as Oversold2025 Risk Factors & Community Verified Watchlist Alerts - beatles.ru
Plus Therapeutics, Inc. shares rise 1.96% intraday after AC Immune's operational efficiencies and pipeline focus. - AInvest
Using data tools to time your Plus Therapeutics Inc. exitQuarterly Earnings Summary & Smart Swing Trading Techniques - Newser
Published on: 2025-09-04 04:06:08 - Newser
Building trade automation scripts for Plus Therapeutics Inc.Jobs Report & Verified Swing Trading Watchlist - Newser
What data driven models say about Plus Therapeutics Inc.’s future2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
How to forecast Plus Therapeutics Inc. trends using time seriesJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Chart overlay techniques for tracking Plus Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - Newser
Plus Therapeutics shares rise 4.68% intraday after announcing participation in H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital - Investing.com Canada
This BorgWarner Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Market reaction to Plus Therapeutics Inc.’s recent news2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Custom watchlist performance reports with Plus Therapeutics Inc2025 Historical Comparison & Weekly Watchlist for Hot Stocks - Newser
Plus Therapeutics Inc. stock momentum explainedMarket Weekly Review & Expert Curated Trade Ideas - Newser
What Fibonacci levels say about Plus Therapeutics Inc. rebound2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
What technical models suggest about Plus Therapeutics Inc.’s comebackWeekly Stock Analysis & Free Community Supported Trade Ideas - Newser
What moving averages say about Plus Therapeutics Inc.2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Plus Therapeutics, Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference 2025 - Quiver Quantitative
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
CNS Cancer Drug Developer Plus Therapeutics Featured at Major H.C. Wainwright Investment Conference - Stock Titan
Ranking Plus Therapeutics Inc. among high performing stocks via toolsJuly 2025 Macro Moves & Real-Time Volume Triggers - Newser
What is Plus Therapeutics Inc. s revenue forecastTrade Performance Summary & High Accuracy Swing Trade Signals - خودرو بانک
Plus Therapeutics Inc (PSTV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):